Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 19

Gossamer Bio Secures Up to $250 Million for Seralutinib

Aug 24, 2026
Gossamer Bio has entered into an agreement with new and existing institutional investors to raise up to approximately $250 million through a private placement. The funding will support…
Read More...

Genentech Plans $750 Million Device Manufacturing Facility in Oregon

Aug 24, 2026
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device fill-finish manufacturing facility at its campus in Hillsboro, Oregon. The…
Read More...

Piramal Pharma Takes Majority Stake in Yapan Bio

Aug 21, 2026
Piramal Pharma has completed the acquisition of an additional 40.67% stake in Yapan Bio, a Hyderabad-based contract development and manufacturing organization (CDMO) focused on vaccines…
Read More...

Charles River and Medigen Partner on Next-Generation Enterovirus Vaccine

Aug 21, 2026
Charles River Laboratories and Medigen Vaccine Biologics have entered into a collaboration to support the development of Medigen’s next-generation multivalent enterovirus vaccine.…
Read More...

WellSpan and Johns Hopkins Expand Cancer Care Collaboration

Aug 21, 2026
WellSpan Health and Johns Hopkins Medicine are expanding their oncology collaboration to improve access to advanced cancer care, specialist expertise and clinical research for patients…
Read More...

SandboxAQ Launches AI Model to Speed Drug Discovery

Aug 21, 2026
SandboxAQ has announced the general availability of AQPotency, an AI-powered model designed to help drug discovery teams predict how strongly potential drug molecules may act on disease…
Read More...

FDA Approves Ultragenyx Gene Therapy for Rare GSDIa Disorder

Aug 21, 2026
Ultragenyx Pharmaceutical has received accelerated approval from the U.S. Food and Drug Administration (FDA) for GENGLYCOS (pariglasgene brecaparvovec-opnr), also known as DTX401, for…
Read More...

Kynexis Raises €40 Million to Advance Cognitive Disorder Drug

Aug 21, 2026
Kynexis, a clinical-stage biotechnology company developing treatments for cognitive problems linked to brain diseases, has raised €40 million in a Series A financing extension. The…
Read More...

FDA Approves Regeneron’s Pasatru for Rare Bone Disorder FOP

Aug 21, 2026
Regeneron Pharmaceuticals has received U.S. Food and Drug Administration approval for Pasatru (garetosmab-grts), a new treatment for adults living with fibrodysplasia ossificans…
Read More...

FDA Grants Fast Track Status to Consano Bio’s Chronic Sciatica Drug

Aug 20, 2026
Consano Bio has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for C-1101, an investigational treatment being developed for chronic, painful…
Read More...
Previous 1 … 17 18 19 20 21 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.